Pesquisar
Ocugen Inc
OCGNAdicionar à lista de desejos
1.050USD
+0.030+2.94%
Horário de mercado 09/14, 12:32（ET）
356.00MValor de mercado
PerdaP/L TTM
Mais detalhes de Ocugen Inc Empresa
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.
Ocugen Inc Perfil
Código da empresaOCGN
Nome da EmpresaOcugen Inc
Data de listagemDec 03, 2014
CEOMusunuri (Shankar)
Número de funcionários95
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 03
Endereço11 Great Valley Parkway
CidadeMALVERN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19355
Telefone14843284701
Sitehttps://ocugen.com/
Código da empresaOCGN
Data de listagemDec 03, 2014
CEOMusunuri (Shankar)
Executivos da empresa Ocugen Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.36M
--
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.36M
--
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
214.50K
--
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
214.50K
--
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
--
--
Ms. Rita Johnson-Greene
Ms. Rita Johnson-Greene
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Mr. Mohamed Genead, M.D.
Mr. Mohamed Genead, M.D.
Interim Chief Medical Officer
Interim Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.36M
--
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.36M
--
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
214.50K
--
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
214.50K
--
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Ocugen Inc?
Os cinco principais acionistas de Ocugen Inc são: Mr. Junge Zhang, Ph.D.
Quantas instituições possuem ações da Ocugen Inc (OCGN)?
Em 2026Q1, 276 instituições possuíam ações da Ocugen Inc, com valor de mercado aproximado de 81.01M, representando 24.06% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 20937.00.